PAVmed Inc. (NASDAQ: PAVM) reported Q3 EPS of ($0.15), $0.12 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $76 thousand versus the consensus estimate of $233.33 thousand.

For earnings history and earnings-related data on PAVmed Inc. (PAVM) click here.